Leveraging current capacity to address the high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in South Africa: Modelling potential costs and benefits of near point-of-care GeneXpert testing for STIs

PLOS Global Public Health · Published 2026-07-24 · DOI 10.1371/journal.pgph.0004480

Free full text

Authors (4)

Nkgomeleng A. Lekodeba, Katherine Snyman, Brooke E. Nichols, Lise Jamieson

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Lekodeba, N., Snyman, K., Nichols, B., et al. (2026). Leveraging current capacity to address the high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in South Africa: Modelling potential costs and benefits of near point-of-care GeneXpert testing for STIs. PLOS Global Public Health. https://doi.org/10.1371/journal.pgph.0004480

Related articles